Dhampur Bio Organics Limited reported a consolidated net profit of ₹25.18 crore for the financial year ended March 31, 2026, driven by higher income from operations. The company's revenue from operations for the year stood at ₹3,133.41 crore, compared to ₹2,696.64 crore in the previous year. For the quarter ended March 31, 2026, the consolidated net profit was ₹46.27 crore, while consolidated revenue from operations reached ₹781.41 crore.

The Board of Directors, at its meeting held on May 30, 2026, approved the audited standalone and consolidated financial results. The board recommended a final dividend of 15%, or ₹1.50 per share, amounting to ₹9.96 crore. The statutory auditors issued an audit report with an unmodified opinion on the financial results. The company noted that the Income Tax Department conducted a search at its premises from October 29, 2025, to November 04, 2025, but stated that no adjustments were required in the financial results regarding the outcome of the search.

Subsequent to the reporting date, the company entered into a Business Transfer Agreement on April 20, 2026, to sell its sugar manufacturing undertaking located at Meerganj, Bareilly, Uttar Pradesh, for an aggregate consideration of ₹305.00 crore. This sale was approved by shareholders in an EGM held on May 18, 2026, and is expected to be completed within 60 days from the execution of the agreement.

Q4 Standalone Performance

On a standalone basis, Dhampur Bio Organics posted Q4 net profit of ₹46.00 crore, compared to ₹39.65 crore in the same period last year. Q4 standalone revenue came in at ₹793.45 crore versus ₹703.57 crore year-on-year. The following table summarises the key standalone Q4 metrics:

While revenue and net profit improved year-on-year, EBITDA declined to ₹95.30 crore from ₹98.50 crore, with the EBITDA margin contracting to 12.13% from 14.03% in the corresponding period of the previous year, indicating higher operating costs relative to revenue.

Standalone Financial Results (FY26)

Consolidated Financial Results (FY26)

Rakesh Agarwal, Vice President – Bottling Operations at dhampur bio organics , resigned from his position effective the close of business hours on May 31, 2026, due to personal reasons. The company disclosed this development in a regulatory filing submitted to the stock exchanges on June 01, 2026. The resignation impacts the senior management structure of the bottling operations division.

The resignation follows a letter tendered by Agarwal on May 31, 2026, wherein he requested to be relieved from his duties with immediate effect. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Details of Resignation

The company provided specific details regarding the cessation of the senior management personnel in the filing. The resignation was categorized under the change in personnel due to resignation, with the effective date set as the end of business hours on May 31, 2026.

The resignation letter was addressed to the Managing Director of Dhampur Bio Organics Limited, with a copy marked to Sudeep Banerjee, Chief Human Resources Officer. The company’s Board and management have accepted the resignation, and the necessary intimations have been sent to the relevant authorities.